Picture loading failed.

Anti-NGFB therapeutic antibody (Pre-made Fulranumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Fulranumab is a monoclonal antibody against nerve growth factor. It was designed for the treatment of pain.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-226-1mg 1mg 3090
GMP-Bios-ab-226-10mg 10mg 21890
GMP-Bios-ab-226-100mg 100mg 148000
GMP-Bios-ab-226-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-NGFB therapeutic antibody (Pre-made Fulranumab biosimilar,Whole mAb)
INN Name Fulranumab
TargetNGFB
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusDiscontinued
100% SI StructureNone
99% SI Structure4m6o:HL
95-98% SI StructureNone
Year Proposed2010
Year Recommended2011
CompaniesJanssen Pharmaceuticals;Janssen Research & Development;Takeda;Amgen
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedPain;Back pain;Cancer pain;Musculoskeletal pain;Neuropathic pain
Development TechAbgenix XenoMouse